glp 1 drops weight loss GLP-1 change: State board coverage of obesity drugs U.S. Obesity Rate Drops as

Significant weight loss from GLP-1 therapy may require levothyroxine dose adjustments, as thyroid hormone needs are partially determined by body weight

Typical starting doses include: Semaglutide (Wegovy): 0.25 mg weekly Tirzepatide (Zepbound): 2.5 mg weekly These starting doses were studied in programs such as the STEP and SURMOUNT trials and were gradually increased to achieve validated metabolic outcomes

Clinical data demonstrate dose-dependent weight loss, with maximum efficacy typically achieved at 1015 mg weekly doses

Is it safe to use grey market tirzepatide if I get it tested first

10.1016/j.cmet.2020.05.001 65 VasuP.DorairajE

61.2% 6